Prosecution Insights
Prosecution Insights
8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (12%) |
| §102 only | 1 (12%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COUGHLIN, MATTHEW P | 1 | 71.4% | +11.9% |
| WELLES, COLMAN THOMAS | 1 | 25.0% | +49.0% |
| SZNAIDMAN, MARCOS L | 1 | 37.2% | +16.0% |
| SAMSELL, RILLA MARIE | 1 | 73.1% | +13.9% |
| BARSKY, JARED | 1 | 50.3% | +23.1% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.4% | +40.1% |
| BERHANE, SELAM | 1 | 59.0% | +55.8% |
| HUANG, GIGI GEORGIANA | 1 | 31.7% | +30.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18832210 | NOVEL SULFATE SALT FORMS OF ISOCHROMAN-IMIDAZOLE STRUCTURED ALPHA-2A ADRENOCEPTOR AGONIST | COUGHLIN, MATTHEW P | — |
| 18730692 | PHARMACEUTICAL COMPOSITION OF A CYP11A1 INHIBITOR | WELLES, COLMAN THOMAS | — |
| 18573360 | PROCESS FOR THE PREPARATION OF A CYP11A1 INHIBITOR AND INTERMEDIATES THEREOF | SAMSELL, RILLA MARIE | — |
| 17796691 | STABLE PHARMACEUTICAL COMPOSITIONS OF ROPINIROLE | HUANG, GIGI GEORGIANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18548487 | NOVEL SALT FORMS OF A 4H-PYRAN-4-ONE STRUCTURED CYP11A1 INHIBITOR | BARSKY, JARED | 72d |
| 18832210 | NOVEL SULFATE SALT FORMS OF ISOCHROMAN-IMIDAZOLE STRUCTURED ALPHA-2A ADRENOCEPTOR AGONIST | COUGHLIN, MATTHEW P | — |
| 18730692 | PHARMACEUTICAL COMPOSITION OF A CYP11A1 INHIBITOR | WELLES, COLMAN THOMAS | — |
| 18696317 | CYP11A1 INHIBITOR FOR USE IN THE TREATMENT OF PROSTATE CANCER | SZNAIDMAN, MARCOS L | — |
| 18573360 | PROCESS FOR THE PREPARATION OF A CYP11A1 INHIBITOR AND INTERMEDIATES THEREOF | SAMSELL, RILLA MARIE | — |
| 18548489 | SOLID FORMS OF A 4H-PYRAN-4-ONE STRUCTURED CYP11A1 INHIBITOR | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 18257761 | CHIMERIC ANTIGEN RECEPTOR (CAR) SPACER MODIFICATIONS ENHANCE CAR T CELL FUNCTIONALITY | BERHANE, SELAM | — |
| 17796691 | STABLE PHARMACEUTICAL COMPOSITIONS OF ROPINIROLE | HUANG, GIGI GEORGIANA | — |
| Art Unit | Apps |
|---|---|
| 1628 | 2 |
| 1624 | 1 |
| 1622 | 1 |
| 1675 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18832210 | NOVEL SULFATE SALT FORMS OF ISOCHROMAN-IMIDAZOLE STRUCTURED ALPHA-2A ADRENOCEPTOR AGONIST | COUGHLIN, MATTHEW P | — | §103§112Other | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18730692 | PHARMACEUTICAL COMPOSITION OF A CYP11A1 INHIBITOR | WELLES, COLMAN THOMAS | — | §103§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18696317 | CYP11A1 INHIBITOR FOR USE IN THE TREATMENT OF PROSTATE CANCER | SZNAIDMAN, MARCOS L | 1628 | §103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18573360 | PROCESS FOR THE PREPARATION OF A CYP11A1 INHIBITOR AND INTERMEDIATES THEREOF | SAMSELL, RILLA MARIE | 1624 | §103§112 | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18548487 | NOVEL SALT FORMS OF A 4H-PYRAN-4-ONE STRUCTURED CYP11A1 INHIBITOR | BARSKY, JARED | 1628 | §103DPOther | Non-Final OA | 72d | Pending | Aug 30, 2023 |
| 18548489 | SOLID FORMS OF A 4H-PYRAN-4-ONE STRUCTURED CYP11A1 INHIBITOR | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103§112DPOther | Non-Final OA | — | Pending | Aug 30, 2023 |
| 18257761 | CHIMERIC ANTIGEN RECEPTOR (CAR) SPACER MODIFICATIONS ENHANCE CAR T CELL FUNCTIONALITY | BERHANE, SELAM | 1675 | §102 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 17796691 | STABLE PHARMACEUTICAL COMPOSITIONS OF ROPINIROLE | HUANG, GIGI GEORGIANA | 1613 | §102§103 | Final Rejection | — | Pending | Aug 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial